Form 8-K - Current report:
SEC Accession No. 0000950170-25-011790
Filing Date
2025-01-31
Accepted
2025-01-31 16:30:08
Documents
11
Period of Report
2025-01-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K meip-20250130.htm   iXBRL 8-K 58972
  Complete submission text file 0000950170-25-011790.txt   172984

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20250130.xsd EX-101.SCH 24867
13 EXTRACTED XBRL INSTANCE DOCUMENT meip-20250130_htm.xml XML 4705
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 25578741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)